Thonar E J, Shinmei M, Lohmander L S
Department of Biochemistry and Internal Medicine, Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.
Rheum Dis Clin North Am. 1993 Aug;19(3):635-57.
Various markers of the metabolism of articular cartilage have been identified in synovial fluid, blood, and urine of patients with osteoarthritis (OA). The joint fluid level of a cartilage-derived molecule, or its fragment, can be used as a marker of the synthesis or catabolism of that molecule in the articular surfaces within that joint. In blood and urine, on the other hand, the level of a marker is useful in assessing systemic changes affecting the metabolism of a molecule in all the cartilages in the body. Quantification of specific markers in body fluids already has proved useful in identifying increased catabolic as well as anabolic activities in articular cartilage during preradiologic as well as later stages of OA. The markers also can be sued for monitoring the effect of drugs on cartilage matrix molecules and in differentiating among different subtypes of osteoarthritis. Markers should prove most useful in prospective studies aimed at identifying early changes in cartilage metabolism in humans at high risk for developing OA.
骨关节炎(OA)患者的滑液、血液和尿液中已鉴定出多种关节软骨代谢标志物。关节液中软骨衍生分子或其片段的水平可作为该分子在该关节关节表面合成或分解代谢的标志物。另一方面,在血液和尿液中,标志物的水平有助于评估影响体内所有软骨中分子代谢的全身变化。体液中特定标志物的定量分析已被证明有助于识别OA放射学前期及后期关节软骨中分解代谢和合成代谢活动的增加。这些标志物还可用于监测药物对软骨基质分子的作用以及区分不同亚型的骨关节炎。在旨在识别有患OA高风险的人群软骨代谢早期变化的前瞻性研究中,标志物应证明是最有用的。